Diagnosis of the antiphospholipid syndrome in anticoagulated patients

scientific article published in December 2004

Diagnosis of the antiphospholipid syndrome in anticoagulated patients is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1022900552
P356DOI10.1007/S00393-004-0593-4
P698PubMed publication ID15605215

P2093author name stringA Engel
M Mohren
I Koetter
T Daikeler
I Guenaydin
P2860cites workAntiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patientsQ33341941
Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patientsQ33447381
Diagnosis of antiphospholipid antibodies.Q33491582
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshopQ33685960
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literatureQ34977289
Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndromeQ35158386
The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody levelQ39289964
International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL SymposiumQ40694046
Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastinsQ45881942
Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndromeQ48610438
Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus AnticoagulantsQ67990133
The relationship between lupus anticoagulants and antibodies to phospholipidQ70370974
Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTHQ70897451
Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTHQ71441084
Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodiesQ71912216
The management of thrombosis in the antiphospholipid-antibody syndromeQ72619159
Antiphospholipid syndromeQ73029663
Guidelines on the investigation and management of the antiphospholipid syndromeQ74121684
Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulantsQ74315013
dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodiesQ74578665
The antiphospholipid syndromeQ77739053
Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LAQ78321143
Anti-beta2-glycoprotein I and anti-prothrombin antibodies in antiphospholipid-negative patients with thrombosis: a case control studyQ78505085
P433issue6
P407language of work or nameGermanQ188
P921main subjectantiphospholipid syndromeQ582207
P1104number of pages5
P304page(s)490-494
P577publication date2004-12-01
P1433published inZeitschrift fuer RheumatologieQ15763293
P1476titleDiagnosis of the antiphospholipid syndrome in anticoagulated patients
P478volume63

Search more.